Alvotech

A global biotech company focused solely on developing and manufacturing biosimilar medicines for patients worldwide, aiming to be a global leader in the biosimilar space through high-quality, cost-effective products and services enabled by a fully integrated approach and broad in-house capabilities. Alvotech's pipeline includes eight biosimilar candidates targeting autoimmune disorders, eye disorders, osteoporosis and cancer.